Quality standard
Quality statements
Quality statements
Statement 1 Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.
Statement 2 Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.
Statement 3 Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.
Statement 4 Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.